Laurion Capital Management LP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 74 filers reported holding INOZYME PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$2,844,782
+104.0%
677,329
+170.5%
0.02%
+112.5%
Q2 2023$1,394,550
-10.5%
250,368
-7.9%
0.01%
-27.3%
Q1 2023$1,557,414
+445.7%
271,8000.0%0.01%
+1000.0%
Q4 2022$285,390
-60.8%
271,8000.0%0.00%
-75.0%
Q3 2022$728,000
-43.8%
271,8000.0%0.00%
-80.0%
Q2 2022$1,296,000
+3061.0%
271,800
+2618.0%
0.02%
+1900.0%
Q1 2022$41,000
-54.9%
10,000
-25.3%
0.00%0.0%
Q4 2021$91,000
-88.9%
13,390
-81.1%
0.00%
-66.7%
Q3 2021$819,000
+303.4%
70,700
+589.8%
0.00%
+200.0%
Q1 2021$203,000
-4.2%
10,2500.0%0.00%
-50.0%
Q4 2020$212,000
-21.2%
10,2500.0%0.00%
-33.3%
Q3 2020$269,00010,2500.00%
Other shareholders
INOZYME PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$18,878,3747.53%
CHI Advisors LLC 1,270,027$5,334,1122.11%
Samsara BioCapital, LLC 1,562,500$6,562,5002.01%
Affinity Asset Advisors, LLC 1,379,852$5,795,3781.63%
Sofinnova Investments, Inc. 4,280,308$17,977,2941.13%
SPHERA FUNDS MANAGEMENT LTD. 1,234,907$5,186,6090.94%
Octagon Capital Advisors LP 1,300,000$5,460,0000.84%
NEA Management Company, LLC 2,437,689$10,238,2940.79%
Knott David M Jr 454,008$1,9070.73%
Rock Springs Capital Management LP 3,681,174$15,460,9310.41%
View complete list of INOZYME PHARMA INC shareholders